Home
NGHIÊN CỨU LÂM SÀNG
Issue: Số 98, 2021
Article
Nguyễn Tá Đông: Bệnh Viện Trung ương Huế;
Nguyễn Đình Đạt: Bệnh Viện Trung ương Huế;
Huỳnh Văn Minh: Bệnh Viện Trung ương Huế;
References
1.
1. Hội Tăng huyết áp Việt Nam (2018). “Khuyến cáo về chẩn đoán và điều trị tăng huyết áp”, Tạp chí Tim mạch học Việt Nam. 70, tr. 150-155.
2.
2. American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines (2018). “2017 ACC/ AHA /AAPA/ ABC/ACPM/ AGS/APhA/ASH /ASPC/ NMA/ PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults”, Journal of the american college of cardiology. 71(19), tr. 127-248.
3.
3. American Diabetes Association (2015). “2015 American Diabetes Association (ADA) Diabetes Guidelines “, Diabetes Care (38(suppl 1)), tr. 1-93
4.
4. Egan B, Bandyopadhyay D và Shaftman SR (2012). “Initial Monotherapy and Combination Therapy and Hypertension Control the First Year”, Hypertension. 59, tr. 1124-1131.
5.
5. Jamerson K và các cộng sự (2008). “Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients”, N Engl J Med. 359, tr. 2417-2428.
6.
6. Julius S và et al (2004). “Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial”, Lancet. 363, tr. 2022-2031.
7.
7. Michel E Bertrand, Roberto Ferrari và Cs (2010). “Clinical synergy of perindopril and calcium channel blocker in the prevention of cardiac events and mortality in patients with coronary artery disease. Post hoc analysis of the EUROPA study”. AHJ vol 159; No 5 may, 2010; p 795-802.
8.
8. Simons LA, Chung E và Ortiz M (2017). “Long-term persistence with single-pill, fixeddose combination therapy versus two pills of amlodipine and perindopril for hypertension: Australian experience”, Current .Medical Research and Opinion. 33(10), tr. 1783-1787.
9.
9. Doreen M. Rabi, MD, MSc, Kerry A. McBrien, MD, MPH, Ruth Sapir-Pichhadze, MD, MSc, PhD, vaf Cs ( 2020). “Hypertension Canada’s 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children”; Canadian Journal of Cardiology Vol 36; 2020; p 596-624.
10.
10. Thomas Unger, Claudio Borghi and Cs. “2020 International Society of Hypertension Global Hypertension Practice Guidelines”. Hypertension Vol 75, N0 6; 2020.